CAS: 1428935-60-7 - Durvalumab
Formula:Unspecified
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Durvalumab REF: TM-T11126CAS: 1428935-60-7 | 98% | 213.00 €~1,990.00 € | Wed 29 May 24 |
 | Durvalumab REF: 3D-DHC93560CAS: 1428935-60-7 | Min. 95% | To inquire | Tue 09 Jul 24 |
Durvalumab
CAS:1428935-60-7
Durvalumab (MEDI 4736) is a humanized monoclonal antibody targeting PD-L1. It can block the interaction …
Purity:
98%
Color and Shape:
Solid
Molecular weight:
N/A
Ref: TM-T11126
| 1mg | 213.00 € | |
| 5mg | 506.00 € | |
| 10mg | 727.00 € | |
| 25mg | 1,103.00 € | |
| 50mg | 1,486.00 € | |
| 100mg | 1,990.00 € |
Estimated delivery in United States, on Wednesday 29 May 2024
Durvalumab
CAS:1428935-60-7
Durvalumab is a human immunoglobulin G1 (IgG1) monoclonal antibody that binds to PD-L1, a protein …
Purity:
Min. 95%
Molecular weight:
1,000 g/mol
Ref: 3D-DHC93560
| 1mg | 736.00 € | |
| 2mg | 935.00 € | |
| 5mg | 1,319.00 € |
Estimated delivery in United States, on Tuesday 9 Jul 2024
